Old Web
English
Sign In
Acemap
>
authorDetail
>
Kathleen Stefunek
Kathleen Stefunek
Cleveland Clinic
in patient
AL amyloidosis
Tolerability
Internal medicine
Medicine
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Updated Organ Response Results of an Open-Label Study to Evaluate the Safety and Tolerability of Cael-101 in Patients with AL Amyloidosis Receiving Anti-Plasma Cell Therapy
2021
Blood
Jason Valent
John Silowsky
Michael R. Kurman
Eileen Daniel
Janet Jobes
Mark Harnett
Sherry Fada
Michael Spector
Kathleen Stefunek
Heather Staley
Kristen Schlueter
Christy J. Samaras
Faiz Anwer
Jack Khouri
Jeffrey A. Zonder
Michaela Liedtke
Susan B. Sobolov
Show All
Source
Cite
Save
Citations (0)
Safety, Tolerability and Efficacy of Cael-101 in AL Amyloidosis Patients Treated on a Phase 2, Open-Label, Dose Selection Study to Evaluate the Safety and Tolerability of Cael-101 in Patients with AL Amyloidosis
2020
Blood
Jack Khouri
Faiz Anwer
Christy Samaras
Alex V. Mejia Garcia
Omer N. Koc
Beth Faiman
Kimberly Hamilton
Saveta Mathur
Cynthia Scott
Kathleen Stefunek
Josephine Sgobbo
Sherry Fada
Brittany Lewis
Kelly Shepherd
Naqib Ahmad
Madeleine Knebusch
Susan B. Sobolov
Janet Jobes
Eileen Daniel
Michael Spector
Jason Valent
Show All
Source
Cite
Save
Citations (2)
1